213 related articles for article (PubMed ID: 23144194)
1. Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies.
Cesano A; Perbellini O; Evensen E; Chu CC; Cioffi F; Ptacek J; Damle RN; Chignola R; Cordeiro J; Yan XJ; Hawtin RE; Nichele I; Ware JR; Cavallini C; Lovato O; Zanotti R; Rai KR; Chiorazzi N; Pizzolo G; Scupoli MT
Haematologica; 2013 Apr; 98(4):626-34. PubMed ID: 23144194
[TBL] [Abstract][Full Text] [Related]
2. Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells.
Palomba ML; Piersanti K; Ziegler CG; Decker H; Cotari JW; Bantilan K; Rijo I; Gardner JR; Heaney M; Bemis D; Balderas R; Malek SN; Seymour E; Zelenetz AD; van den Brink MR; Altan-Bonnet G
PLoS One; 2014; 9(1):e79987. PubMed ID: 24489640
[TBL] [Abstract][Full Text] [Related]
3. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
4. SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course.
Dezorella N; Katz BZ; Shapiro M; Polliack A; Perry C; Herishanu Y
Haematologica; 2016 Dec; 101(12):1553-1562. PubMed ID: 27443285
[TBL] [Abstract][Full Text] [Related]
5. Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.
Blix ES; Irish JM; Husebekk A; Delabie J; Forfang L; Tierens AM; Myklebust JH; Kolstad A
BMC Cancer; 2012 Oct; 12():478. PubMed ID: 23072591
[TBL] [Abstract][Full Text] [Related]
6. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
[TBL] [Abstract][Full Text] [Related]
8. Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival.
Wang YH; Fan L; Wang L; Zhang R; Zou ZJ; Fang C; Zhang LN; Li JY; Xu W
Leuk Lymphoma; 2013 Jun; 54(6):1165-70. PubMed ID: 23039362
[TBL] [Abstract][Full Text] [Related]
9. The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia.
Wiestner A
Haematologica; 2015 Dec; 100(12):1495-507. PubMed ID: 26628631
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG
Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849
[TBL] [Abstract][Full Text] [Related]
11. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
Shukla A; Rai K; Shukla V; Chaturvedi NK; Bociek RG; Pirruccello SJ; Band H; Lu R; Joshi SS
Blood; 2016 May; 127(19):2310-21. PubMed ID: 26809508
[TBL] [Abstract][Full Text] [Related]
12. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
[TBL] [Abstract][Full Text] [Related]
13. SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia.
Paiva C; Rowland TA; Sreekantham B; Godbersen C; Best SR; Kaur P; Loriaux MM; Spurgeon SEF; Danilova OV; Danilov AV
Haematologica; 2017 Nov; 102(11):1890-1900. PubMed ID: 28838991
[TBL] [Abstract][Full Text] [Related]
14. Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia.
Feng G; Wang X
Leuk Lymphoma; 2014 Dec; 55(12):2699-705. PubMed ID: 24547708
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells.
Wilmore S; Rogers-Broadway KR; Taylor J; Lemm E; Fell R; Stevenson FK; Forconi F; Steele AJ; Coldwell M; Packham G; Yeomans A
Cell Mol Life Sci; 2021 Sep; 78(17-18):6337-6349. PubMed ID: 34398253
[TBL] [Abstract][Full Text] [Related]
16. B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients.
Nédellec S; Renaudineau Y; Bordron A; Berthou C; Porakishvili N; Lydyard PM; Pers JO; Youinou P
J Immunol; 2005 Mar; 174(6):3749-56. PubMed ID: 15749915
[TBL] [Abstract][Full Text] [Related]
17. Activation of extracellular signal-regulated kinase through B-cell antigen receptor in B-cell chronic lymphocytic leukemia.
Kawauchi K; Ogasawara T; Yasuyama M
Int J Hematol; 2002 Jun; 75(5):508-13. PubMed ID: 12095152
[TBL] [Abstract][Full Text] [Related]
18. High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia.
Herling M; Patel KA; Weit N; Lilienthal N; Hallek M; Keating MJ; Jones D
Blood; 2009 Nov; 114(21):4675-86. PubMed ID: 19770358
[TBL] [Abstract][Full Text] [Related]
19. The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia.
Le Roy C; Deglesne PA; Chevallier N; Beitar T; Eclache V; Quettier M; Boubaya M; Letestu R; Lévy V; Ajchenbaum-Cymbalista F; Varin-Blank N
Blood; 2012 Jul; 120(2):356-65. PubMed ID: 22613791
[TBL] [Abstract][Full Text] [Related]
20. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
Herishanu Y; Pérez-Galán P; Liu D; Biancotto A; Pittaluga S; Vire B; Gibellini F; Njuguna N; Lee E; Stennett L; Raghavachari N; Liu P; McCoy JP; Raffeld M; Stetler-Stevenson M; Yuan C; Sherry R; Arthur DC; Maric I; White T; Marti GE; Munson P; Wilson WH; Wiestner A
Blood; 2011 Jan; 117(2):563-74. PubMed ID: 20940416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
